Search results
Can Pharming Group N.V. Sponsored ADR (PHAR) Run Higher on Rising Earnings Estimates?
Zacks via Yahoo Finance· 2 years agoPharming Group N.V. Sponsored ADR (PHAR) shares have started gaining and might continue moving...
Pharming Group N.V. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Simply Wall St. via Yahoo Finance· 2 years agoInvestors in Pharming Group N.V. (AMS:PHARM) had a good week, as its shares rose 2.2% to close at...
Pharming Group N.V. Sponsored ADR (PHAR) Soars 14.7%: Is Further Upside Left in the Stock?
Zacks via Yahoo Finance· 8 months agoPharming Group N.V. Sponsored ADR (PHAR) saw its shares surge in the last session with trading...
Pharming Group (PHAR) Surges 7.2%: Is This an Indication of Further Gains?
Zacks via Yahoo Finance· 3 weeks agoPharming Group (PHAR) saw its shares surge in the last session with trading volume being higher than...
Pharming Group N.V. (AMS:PHARM) Analysts Are Pretty Bullish On The Stock After Recent Results
Simply Wall St. via Yahoo Finance· 2 months agoPharming Group N.V. (AMS:PHARM) came out with its yearly results last week, and we wanted to see how...
Pharming Group N.V.'s (AMS:PHARM) Fundamentals Look Pretty Strong: Could The Market Be Wrong About...
Simply Wall St. via Yahoo Finance· 1 year agoWith its stock down 8.5% over the past three months, it is easy to disregard Pharming Group...
Pharming (PHAR) Rare Disease Drug Joenja Gets FDA Nod, Stock Up
Zacks via Yahoo Finance· 1 year agoPharming Group (PHAR) obtains FDA approval for leniolisib for the treatment of a rare pediatric...
Has Pharming Group (PHAR) Outpaced Other Medical Stocks This Year?
Zacks via Yahoo Finance· 1 year agoInvestors interested in Medical stocks should always be looking to find the best-performing...
Pharming Group N.V.'s (AMS:PHARM) Intrinsic Value Is Potentially 49% Above Its Share Price
Simply Wall St. via Yahoo Finance· 1 year agoToday we'll do a simple run through of a valuation method used to estimate the attractiveness of...
Pharming Group Full Year 2022 Earnings: EPS: US$0.021 (vs US$0.025 in FY 2021)
Simply Wall St. via Yahoo Finance· 1 year agoPharming Group (AMS:PHARM) Full Year 2022 Results Key Financial Results Revenue: US$205.6m (up 3.4%...